Tech Company Financing Transactions

EXIMIAS Pharmaceutical Funding Round

Birchmere Ventures, Cross Atlantic Capital Partners and Easton Capital participated in a $63.5 million Series D funding round for EXIMIAS Pharmaceutical. The round was announced on 3/31/2004.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

1055 Westlakes Drive 200
Berwyn, PA 19312
USA

Phone

(610) 560-0600

Website

www.eximiaspharm.com

Email Address

[email protected]

Overview

EXIMIAS Pharmaceutical Corporation focuses on the acquisition, development and commercialization of unique oncology and infectious disease products.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

        

Browse more venture capital transactions:

Prev: 3/31/2004: NextHop Technologies venture capital transaction
Next: 4/1/2004: LiveOps venture capital transaction

Share this article

News on VC Transactions

We report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary